Image
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Affordable diabetes treatment is critical for improving health outcomes, especially for the financially vulnerable.
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
The landscape of liver disease treatment is evolving rapidly. With new diagnostic tools and promising therapies in development, the future of MASH care is brighter than ever.
Learn how health plans can address LGBTQ+ health disparities and promote inclusive health care practices.